{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-014557","form_type":"8-K","ticker":"MBOT","cik":"0000883975","company_name":"Microbot Medical Inc.","filed_at":"2025-09-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.578827+00:00","generated_at":"2026-05-17T05:56:00.013489+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Microbot Medical CEO to Discuss LIBERTY FDA Clearance and Commercialization on Benzinga Interview Sept 24","bullets":["CEO Harel Gadot will be interviewed on Benzinga All Access at 10:45am ET on September 24, 2025.","Discussion will cover recent FDA 510(k) clearance of the LIBERTY Endovascular Robotic System.","FDA clearance for LIBERTY was announced on September 8, 2025.","Company plans for U.S. commercialization of the peripheral endovascular system.","LIBERTY is described as the first single-use, remotely operated robotic solution for endovascular procedures."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-014557","json":"https://secwatch.observer/filing/0001493152-25-014557.json","markdown":"https://secwatch.observer/filing/0001493152-25-014557.md","text":"https://secwatch.observer/filing/0001493152-25-014557.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883975/000149315225014557/0001493152-25-014557-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883975/000149315225014557/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:56:00.013489+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}